Showing results (191-200 of 214) with videos related to

Sort By:
Pageof 22
The Journal of Clinical Investigation|February 11, 2021
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replicationPablo Tebas, Julie K Jadlowsky, Pamela A Shaw, et al.
Biomaterials|August 11, 2022
Debulking different Corona (SARS-CoV-2 delta, omicron, OC43) and Influenza (H1N1, H3N2) virus strains by plant viral trap proteins in chewing gums to decrease infection and transmissionHenry Daniell, Smruti K Nair, Hancheng Guan, et al.
JAMA Network Open|January 25, 2022
Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19: A Meta-analysisAndrea B Troxel, Eva Petkova, Keith Goldfeld, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: VilobelimabNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 20, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: InfliximabNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
AIDS (London, England)|December 5, 2023
The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapyJeffrey M Jacobson, Barbara K Felber, Huichao Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: AbataceptNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical IllnessAdarsh Bhimraj, Yngve Falck-Ytter, Lindsey R Baden, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2026
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Baricitinib vs. TocilizumabNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2026
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in AdultsAmy Hirsch Shumaker, Adarsh Bhimraj, Roger Bedimo, et al.
Pageof 22